SOX18 and Kaposi's sarcoma: Therefore, we investigated here whether KSHV-infected lymphatic ECFCs engrafted into NSG mice could serve as a physiologically relevant infection model to test the potential of SOX18 inhibition as a therapeutic modality for KS.